Bcr-abl Positive Acute Lymphoblastic Leukemia

Top drugs studied for this disease

All Approvals Safety alerts Label changes Trial results Research Guidance Withdrawals

CLINICAL_TRIALS trial_result · 2021-11-30
Clinical Trial Update: Phase II Front-line Ponatinib in Adult Philadelphia+/BCR-ABL+ Acute Lymphoblastic Leukemia. [Phase 2]
Phase II study of front-line ponatinib in adults with Philadelphia-positive/BCR-ABL-positive acute lymphoblastic leukemia has completed.